Abstract: The invention concerns an ophthalmic composition comprising a beta-blocker solution, said composition being obtained by dissolving in water beta-blocker in the presence of alginic acid and adding an alkaline base, to obtain a solution with the PH of 6 to 8. Said composition has a sustained duration of action.

Abstract: The subject of this invention is a ready-for-use collyrium intended for the treatment of ocular allergies, comprising, in aqueous solution, mequitazine and a .beta.- or a .gamma.-cyclodextrin optionally etherified by C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the said cyclodextrin being present in at least a molar ratio of at least one in relation to mequitazine.

Abstract: The present invention relates to a ready-to-use indomethacin eye lotion comprising, in aqueous solution:indomethacin,a .beta.- or .gamma.-cyclodextrin etherified with C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the cyclodextrin being present in a molar ratio with respect to the indomethacin of at least 10/1, and the pH of the solution being from 4.0 to 6.0.

Abstract: The object of the invention is an ophthalmic composition containing between 0.1 to 10% by weight of paracetamol in an ophthalmic excipient.

Abstract: The invention relates to compounds of the formula ##STR1## These compounds may be used in therapeutics for the treatment of acne, psoriasis, disorders of keratinization, in certain forms of cancer and as healing agents, particularly in the ocular field.

Abstract: The invention relates to a process for the treatment of glaucoma comprising administering to a human in need thereof an effective amount of a compound selected from the inhibitors of xanthine-oxidase.

Abstract: Buffered opthalmic solutions of indomethacin.

Abstract: The subject of the invention is N-substituted 2-aminothiazoles of formula ##STR1## in which: X is a C--H group or a nitrogen atom,R.sub.1 and R.sub.2 are, independently of each other, a hydrogen atom, a halogen atom or an alkyl, alkoxy, alkylthio, alkenyloxy, cycloalkyl, trifluoromethyl, nitro, amino, (C.sub.1 -C.sub.6 alkyl)amino or di(C.sub.1 -C.sub.6 alkyl)-amino radical, andR.sub.3 is a hydrogen atom, a --CH.sub.2 --OH group or a --COOR.sub.4 group, R.sub.4 being a hydrogen atom or an alkyl group,and also the pharmaceutically acceptable salts thereof.These compounds have an anti-inflammatory and antiallergic activity and can be used in therapy, especially in the ocular field.

Abstract: Compounds having the formula (I) wherein R.sub.1 and R.sub.2 are a hydrogen atom, an alkyl group or a hydroxy group, or else R.sub.1 and R.sub.2 form together a bivalent ethylene or trimethylene radical; R.sub.3 is a halogen atom, an alkyl group, an alkoxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or di-alkyl amino group, an acetamido or sulfonamido group; R.sub.1 is a hydroxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or dialkyl amino group, an acetamido or sulfonamido group; R.sub.4 being in the position 3, 4 or 5 and A is a bridge having from 1 to 3 links selected among the groups having the formula (II), --NH--,--N.dbd.--O-- and --S--. R.sub.5 represents an hydrogen atom, an alkyl group, a hydroxy group or an alkoxy group as well as the addition salts thereof with pharmaceutically acceptable acids. Said compound may be used in therapeutical treatment as antihypertensive agents, particularly in the ocular field.

Abstract: This invention relates to therapeutic compositions comprising, as active ingredient, N-substituted hydrazones having the formula: ##STR1## in which Z is a 2-thienyl or phenyl radical. Said compositions have an anti-inflammatory activity, particularly in the ocular field.

Abstract: This invention relates to a therapeutic composition comprising, as active ingredient, a compound of the formula (I) ##STR1## in which R is hydrogen or an ether or ester residue, or a therapeutically acceptable acid addition salt thereof.This composition is applicable to the treatment and the prevention of thromboses.

Abstract: This invention relates to compounds having the formula: ##STR1## in which: R represents a C.sub.1-6 alkyl radical or a C.sub.1-6 alkenyl radical; A represents an indazol-2,3- or 4,5- or 6,7-diyl radical, which indazoldiyl radical may be substituted on the nitrogen atoms at 1- or 2-position with C.sub.1-6 alkyl or phenyl-(C.sub.1-6) alkyl radicals, and their salts with pharmaceutically acceptable bases.Said compounds are therapeutically useful as antibacterial agents.